IVIG Advocacy Group Formed To Present Unified Voice On Product Access
Executive Summary
In the wake of two recent reports offering a comprehensive examination of intravenous immune globulin payment and supply, a new IVIG organization has formed the Alliance for Plasma Therapies. Its goal is to bring all interested stakeholders together to present a unified call for legislative action addressing what it calls the IVIG "access crisis.
You may also be interested in...
IVIG Access Issues Highlighted In Effort To Eliminate Specialty Drug Tiers
Continued problems with patient access to intravenous immune globulin therapies is helping patient advocacy groups put the spotlight on payers' handling of IVIG on their formularies and make a push for eliminating the use of specialty drug tiers
IVIG Access Issues Highlighted In Effort To Eliminate Specialty Drug Tiers
Continued problems with patient access to intravenous immune globulin therapies is helping patient advocacy groups put the spotlight on payers' handling of IVIG on their formularies and make a push for eliminating the use of specialty drug tiers
AHRQ Comparative Effectiveness Funding Doubled In 2008 Budget Bills
Funding for medical product comparative effectiveness research within the HHS Agency for Healthcare Research and Quality would increase to $30 million in fiscal year 2008 appropriations legislation pending in both the House and Senate
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: